Accretion Pharmaceuticals Limited

ACCPL

Half-yearly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 202655

    Half year₹ croreYoY
    Mar 202539—
    Sept 202544—
    Mar 202646+18.2%
    Sept 202655+25.8%
  • ₹ crore

    Sept 20260.15

    Half year₹ crore
    Mar 20250.08
    Sept 20250.11
    Mar 20260.08
    Sept 20260.15
  • ₹ crore

    Sept 202655

    Half year₹ crore
    Mar 202539
    Sept 202544
    Mar 202646
    Sept 202655
  • Cost structure
  • ₹ crore

    Sept 20262

    Half year₹ crore
    Mar 20252
    Sept 20252
    Mar 20262
    Sept 20262
  • ₹ crore

    Sept 202644

    Half year₹ crore
    Mar 202532
    Sept 202537
    Mar 202639
    Sept 202644
  • Exceptional items and tax
  • ₹ crore

    Sept 202611

    Half year₹ crore
    Mar 20256
    Sept 20256
    Mar 20267
    Sept 202611
  • ₹ crore

    Sept 20263

    Half year₹ crore
    Mar 20252
    Sept 20252
    Mar 20262
    Sept 20263
  • Profit
  • ₹ crore

    Sept 20268

    Half year₹ croreYoY
    Mar 20254—
    Sept 20255—
    Mar 20265+13.5%
    Sept 20268+72.6%
  • Per share
  • ₹ per share

    Sept 20267.38

    Half year₹ per share
    Mar 20255.30
    Sept 20254.61
    Mar 20264.42
    Sept 20267.38
₹ croreMar 2025Sept 2025Mar 2026Sept 2026
Income
39444655
Revenue YoY——+18.2%+25.8%
0.080.110.080.15
39444655
Cost structure
2222
32373944
Exceptional items and tax
66711
2223
Profit
4558
Net profit YoY——+13.5%+72.6%
Per share
5.304.614.427.38

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 4 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.